Breaking News Instant updates and real-time market news.

CBIO

Catalyst Biosciences

/

+

, VRTX

Vertex Pharmaceuticals

$258.71 /

+3.265 (+1.28%)

08:32
05/23/22
05/23
08:32
05/23/22
08:32

Catalyst Biosciences sells complement portfolio for $60M

Catalyst Biosciences (CBIO) announced that it has signed a definitive asset purchase and sale agreement with Vertex Pharmaceuticals (VRTX) under which Vertex has acquired Catalyst's portfolio of protease medicines that regulate complement, including CB 2782-PEG, for $60M in cash. "We have been exploring strategic alternatives to monetize our assets and maximize value for our shareholders. This sale is part of the ongoing strategic process that we announced in February to explore alternatives and create value for shareholders. We have significantly reduced our cash burn and continue to work with our advisors to evaluate additional strategic alternatives for Catalyst," said Nassim Usman, Ph.D., Chief Executive Officer of Catalyst Biosciences.

CBIO

Catalyst Biosciences

/

+

VRTX

Vertex Pharmaceuticals

$258.71 /

+3.265 (+1.28%)

  • 03

    Jun

OTHER BREAKING NEWS FROM THE FLY

Recommendations
Paychex price target lowered to $125 from $145 at Citi » 06:19
07/07/22
07/07
06:19
07/07/22
06:19
PAYX

Paychex

$116.96 /

+1.49 (+1.29%)

Citi analyst Peter…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PAYX Paychex
$116.96 /

+1.49 (+1.29%)

PAYX Paychex
$116.96 /

+1.49 (+1.29%)

06/30/22 Baird
Paychex price target lowered to $130 from $142 at Baird
06/30/22 Morgan Stanley
Paychex price target lowered to $130 from $140 at Morgan Stanley
06/30/22 Cowen
Paychex price target lowered to $135 from $140 at Cowen
06/30/22 Deutsche Bank
Paychex price target lowered to $123 from $145 at Deutsche Bank
PAYX Paychex
$116.96 /

+1.49 (+1.29%)

PAYX Paychex
$116.96 /

+1.49 (+1.29%)

Recommendations
MarketAxess price target lowered to $305 from $316 at Credit Suisse » 06:18
07/07/22
07/07
06:18
07/07/22
06:18
MKTX

MarketAxess

$259.57 /

-5.06 (-1.91%)

Credit Suisse analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MKTX MarketAxess
$259.57 /

-5.06 (-1.91%)

MKTX MarketAxess
$259.57 /

-5.06 (-1.91%)

07/01/22 Piper Sandler
MarketAxess price target lowered to $285 from $300 at Piper Sandler
06/27/22 Jefferies
MarketAxess price target lowered to $300 from $315 at Jefferies
06/10/22 Atlantic Equities
MarketAxess price target lowered to $306 from $340 at Atlantic Equities
05/19/22 Deutsche Bank
MarketAxess price target lowered to $270 from $300 at Deutsche Bank
MKTX MarketAxess
$259.57 /

-5.06 (-1.91%)

Recommendations
DoorDash price target lowered to $118 from $138 at Citi » 06:18
07/07/22
07/07
06:18
07/07/22
06:18
DASH

DoorDash

$69.36 /

-5.535 (-7.39%)

Citi analyst Ronald Josey…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
DASH DoorDash
$69.36 /

-5.535 (-7.39%)

DASH DoorDash
$69.36 /

-5.535 (-7.39%)

06/29/22 JPMorgan
DoorDash price target lowered to $90 from $100 at JPMorgan
06/27/22 Needham
DoorDash price target lowered to $100 from $140 at Needham
06/21/22 Goldman Sachs
DoorDash reinstated with a Neutral at Goldman Sachs
06/06/22 Raymond James
DoorDash initiated with a Market Perform at Raymond James
DASH DoorDash
$69.36 /

-5.535 (-7.39%)

  • 19
    Aug
DASH DoorDash
$69.36 /

-5.535 (-7.39%)

DASH DoorDash
$69.36 /

-5.535 (-7.39%)

DASH DoorDash
$69.36 /

-5.535 (-7.39%)

Hot Stocks
FDA discusses efforts to increase infant formula supply » 06:17
07/07/22
07/07
06:17
07/07/22
06:17
ABT

Abbott

$108.68 /

-0.61 (-0.56%)

, RBGLY

Reckitt Benckiser

$15.40 /

+0.29 (+1.92%)

On Feb. 17, 2022, the FDA…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ABT Abbott
$108.68 /

-0.61 (-0.56%)

ABT Abbott
$108.68 /

-0.61 (-0.56%)

07/06/22 Wolfe Research
Wolfe starts Abbott at Underperform, says stock price 'doesn't make sense'
07/06/22 Wolfe Research
Wolfe Research starts 'Goldilocks stock' Boston Scientific at Outperform
07/05/22 Wolfe Research
Abbott initiated with an Underperform at Wolfe Research
07/05/22 Evercore ISI
Evercore adds Abbott to 'Tactical Underperform' list, lowers target to $116
RBGLY Reckitt Benckiser
$15.40 /

+0.29 (+1.92%)

06/24/22 Barclays
Reckitt Benckiser price target lowered to 8,600 GBp from 9,300 GBp at Barclays
05/18/22 RBC Capital
Reckitt Benckiser upgraded to Outperform from Sector Perform at RBC Capital
05/09/22 Morgan Stanley
Reckitt Benckiser price target raised to 7,100 GBp at Morgan Stanley
05/03/22 RBC Capital
Reckitt Benckiser price target raised to 5,900 GBp at RBC Capital
ABT Abbott
$108.68 /

-0.61 (-0.56%)

ABT Abbott
$108.68 /

-0.61 (-0.56%)

RBGLY Reckitt Benckiser
$15.40 /

+0.29 (+1.92%)

ABT Abbott
$108.68 /

-0.61 (-0.56%)

RBGLY Reckitt Benckiser
$15.40 /

+0.29 (+1.92%)

ABT Abbott
$108.68 /

-0.61 (-0.56%)

Periodicals
AT&T employees ask judge to throw out lawsuit by SEC, Bloomberg reports » 06:17
07/07/22
07/07
06:17
07/07/22
06:17
T

AT&T

$21.09 /

-0.08 (-0.38%)

AT&T and three…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
T AT&T
$21.09 /

-0.08 (-0.38%)

T AT&T
$21.09 /

-0.08 (-0.38%)

06/28/22 Scotiabank
AT&T assumed with a Sector Perform at Scotiabank (yesterday)
06/16/22 Tigress Financial
AT&T price target lowered to $28 from $31 at Tigress Financial
06/02/22 Wolfe Research
AT&T price target lowered to $22 from $27 at Wolfe Research
05/31/22 LightShed Partners
Verizon initiated with a Neutral at LightShed Partners
T AT&T
$21.09 /

-0.08 (-0.38%)

T AT&T
$21.09 /

-0.08 (-0.38%)

T AT&T
$21.09 /

-0.08 (-0.38%)

T AT&T
$21.09 /

-0.08 (-0.38%)

Upgrade
Pinnacle Financial upgraded to Outperform from Market Perform at Raymond James » 06:17
07/07/22
07/07
06:17
07/07/22
06:17
PNFP

Pinnacle Financial

$72.45 /

-1.14 (-1.55%)

Raymond James analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PNFP Pinnacle Financial
$72.45 /

-1.14 (-1.55%)

PNFP Pinnacle Financial
$72.45 /

-1.14 (-1.55%)

07/01/22 JPMorgan
Pinnacle Financial price target lowered to $95 from $123 at JPMorgan
06/15/22 Truist
Pinnacle Financial price target lowered to $92 from $100 at Truist
04/20/22 Truist
Pinnacle Financial price target lowered to $100 from $124 at Truist
04/07/22 Jefferies
Pinnacle Financial initiated with a Hold at Jefferies
PNFP Pinnacle Financial
$72.45 /

-1.14 (-1.55%)

PNFP Pinnacle Financial
$72.45 /

-1.14 (-1.55%)

PNFP Pinnacle Financial
$72.45 /

-1.14 (-1.55%)

Upgrade
Regions Financial upgraded to Outperform from Market Perform at Raymond James » 06:16
07/07/22
07/07
06:16
07/07/22
06:16
RF

Regions Financial

$18.57 /

-0.265 (-1.41%)

Raymond James analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
RF Regions Financial
$18.57 /

-0.265 (-1.41%)

RF Regions Financial
$18.57 /

-0.265 (-1.41%)

06/15/22 Truist
Regions Financial price target lowered to $25 from $27 at Truist
06/02/22 Keefe Bruyette
Regions upgraded to Market Perform from Underperform at Keefe Bruyette
05/26/22 Wolfe Research
Regions Financial price target lowered to $20 from $24 at Wolfe Research
04/11/22 Wells Fargo
Wells Fargo upgrades Regions Financial to Overweight, raises price target to $26
RF Regions Financial
$18.57 /

-0.265 (-1.41%)

RF Regions Financial
$18.57 /

-0.265 (-1.41%)

Recommendations
Eli Lilly price target raised to $355 from $333 at Barclays » 06:16
07/07/22
07/07
06:16
07/07/22
06:16
LLY

Eli Lilly

$330.19 /

+3.125 (+0.96%)

Barclays analyst Carter…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
LLY Eli Lilly
$330.19 /

+3.125 (+0.96%)

LLY Eli Lilly
$330.19 /

+3.125 (+0.96%)

06/06/22 Mizuho
Weight loss data sets up more upside in Lilly shares, says Mizuho
06/01/22 JPMorgan
Eli Lilly price target raised to $355 from $340 at JPMorgan
05/23/22 SVB Leerink
Eli Lilly initiated with an Outperform at SVB Leerink
05/02/22 Wells Fargo
AbbVie price target raised to $200 from $165 at Wells Fargo
LLY Eli Lilly
$330.19 /

+3.125 (+0.96%)

LLY Eli Lilly
$330.19 /

+3.125 (+0.96%)

LLY Eli Lilly
$330.19 /

+3.125 (+0.96%)

LLY Eli Lilly
$330.19 /

+3.125 (+0.96%)

Initiation
GitLab initiated with a Buy at Needham » 06:15
07/07/22
07/07
06:15
07/07/22
06:15
GTLB

GitLab

$56.00 /

-3.11 (-5.26%)

Needham analyst Mike…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
GTLB GitLab
$56.00 /

-3.11 (-5.26%)

GTLB GitLab
$56.00 /

-3.11 (-5.26%)

06/27/22 Goldman Sachs
GitLab upgraded to Buy from Neutral at Goldman Sachs
06/09/22 Scotiabank
Scotiabank starts GitLab at Outperform with $62 price target
06/08/22 Scotiabank
GitLab initiated with an Outperform at Scotiabank
06/07/22 UBS
GitLab price target raised to $59 from $54 at UBS
GTLB GitLab
$56.00 /

-3.11 (-5.26%)

  • 14
    Oct
GTLB GitLab
$56.00 /

-3.11 (-5.26%)

GTLB GitLab
$56.00 /

-3.11 (-5.26%)

Recommendations
Dish price target lowered to $19 from $25 at Barclays » 06:15
07/07/22
07/07
06:15
07/07/22
06:15
DISH

Dish

$18.12 /

-0.33 (-1.79%)

Barclays analyst Kannan…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
DISH Dish
$18.12 /

-0.33 (-1.79%)

DISH Dish
$18.12 /

-0.33 (-1.79%)

07/01/22 Raymond James
T-Mobile price target raised to $160 from $158 at Raymond James
06/22/22 Truist
Dish's recent weakness offers 'new low entry point,' says Truist
05/31/22 Truist
Truist upgraded Dish to Buy given its spectrum holdings, valuation, and market
05/31/22 Truist
Dish upgraded to Buy from Hold at Truist
DISH Dish
$18.12 /

-0.33 (-1.79%)

DISH Dish
$18.12 /

-0.33 (-1.79%)

DISH Dish
$18.12 /

-0.33 (-1.79%)

DISH Dish
$18.12 /

-0.33 (-1.79%)

Recommendations
Shopify price target lowered to $50 from $500 after stock split at Oppenheimer » 06:15
07/07/22
07/07
06:15
07/07/22
06:15
SHOP

Shopify

$32.99 /

-1.02 (-3.00%)

Oppenheimer analyst Brian…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SHOP Shopify
$32.99 /

-1.02 (-3.00%)

SHOP Shopify
$32.99 /

-1.02 (-3.00%)

07/06/22 Oppenheimer
Shopify target adjusted to $50 for stock split at Oppenheimer
07/05/22 Truist
Shopify price target lowered to $35 from $450 at Truist
07/05/22 JMP Securities
Shopify initiated with a Market Perform at JMP Securities
06/29/22 Stifel
Shopify price target adjusted to $65 at Stifel to reflect split
SHOP Shopify
$32.99 /

-1.02 (-3.00%)

SHOP Shopify
$32.99 /

-1.02 (-3.00%)

SHOP Shopify
$32.99 /

-1.02 (-3.00%)

SHOP Shopify
$32.99 /

-1.02 (-3.00%)

Upgrade
PPL Corp. upgraded to Outperform from In Line at Evercore ISI » 06:14
07/07/22
07/07
06:14
07/07/22
06:14
PPL

PPL Corp.

$27.04 /

+0.23 (+0.86%)

Evercore ISI analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PPL PPL Corp.
$27.04 /

+0.23 (+0.86%)

PPL PPL Corp.
$27.04 /

+0.23 (+0.86%)

06/07/22 Wells Fargo
PPL Corp. price target raised to $34 from $33 at Wells Fargo
05/30/22 Goldman Sachs
PPL Corp. reinstated with a Buy at Goldman Sachs
04/25/22 Credit Suisse
PPL Corp. initiated with an Outperform at Credit Suisse
04/04/22 Argus
PPL Corp. downgraded to Hold from Buy at Argus
PPL PPL Corp.
$27.04 /

+0.23 (+0.86%)

Recommendations
CytomX Therapeutics price target lowered to $3.50 from $7 at Barclays » 06:14
07/07/22
07/07
06:14
07/07/22
06:14
CTMX

CytomX Therapeutics

$1.96 /

+0.015 (+0.77%)

Barclays analyst Peter…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CTMX CytomX Therapeutics
$1.96 /

+0.015 (+0.77%)

CTMX CytomX Therapeutics
$1.96 /

+0.015 (+0.77%)

04:44 Today Mizuho
CytomX Therapeutics downgraded to Neutral from Buy at Mizuho
04:42 Today Piper Sandler
CytomX Therapeutics downgraded to Neutral from Overweight at Piper Sandler
06/23/22 BMO Capital
CytomX Therapeutics initiated with an Outperform at BMO Capital
05/27/22 Piper Sandler
CytomX Therapeutics price target lowered to $10 from $16 at Piper Sandler
CTMX CytomX Therapeutics
$1.96 /

+0.015 (+0.77%)

CTMX CytomX Therapeutics
$1.96 /

+0.015 (+0.77%)

Hot Stocks
Torex Gold Resources reports results of expansion drilling in Media Luna » 06:14
07/07/22
07/07
06:14
07/07/22
06:14
TORXF

Torex Gold Resources

$6.96 /

-0.2275 (-3.17%)

Torex Gold Resources…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TORXF Torex Gold Resources
$6.96 /

-0.2275 (-3.17%)

TORXF Torex Gold Resources
$6.96 /

-0.2275 (-3.17%)

05/27/22 Stifel
Torex Gold Resources price target raised to C$25.50 from C$25 at Stifel
05/12/22 Scotiabank
Torex Gold Resources price target raised to C$23 from C$22 at Scotiabank
04/20/22 National Bank
Torex Gold Resources price target lowered to C$22 from C$23.25 at National Bank
04/07/22 BMO Capital
Torex Gold Resources price target lowered to C$23 from C$28 at BMO Capital
Recommendations
Walmart removed as a Top Pick at Oppenheimer » 06:13
07/07/22
07/07
06:13
07/07/22
06:13
WMT

Walmart

$125.09 /

+0.97 (+0.78%)

Oppenheimer analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
WMT Walmart
$125.09 /

+0.97 (+0.78%)

WMT Walmart
$125.09 /

+0.97 (+0.78%)

06/27/22 Goldman Sachs
Walmart price target lowered to $138 from $160 at Goldman Sachs
06/23/22 Baird
Symbotic initiated with an Outperform at Baird
06/21/22 Cowen
Symbotic initiated with an Outperform at Cowen
06/17/22 Truist
Deal with Walmart an 'incremental positive' for Roku, says Truist
WMT Walmart
$125.09 /

+0.97 (+0.78%)

WMT Walmart
$125.09 /

+0.97 (+0.78%)

WMT Walmart
$125.09 /

+0.97 (+0.78%)

WMT Walmart
$125.09 /

+0.97 (+0.78%)

Recommendations
RLJ Lodging Trust price target lowered to $15 from $18 at Barclays » 06:13
07/07/22
07/07
06:13
07/07/22
06:13
RLJ

RLJ Lodging Trust

$10.86 /

-0.26 (-2.34%)

Barclays analyst Anthony…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
RLJ RLJ Lodging Trust
$10.86 /

-0.26 (-2.34%)

RLJ RLJ Lodging Trust
$10.86 /

-0.26 (-2.34%)

04/21/22 Oppenheimer
Oppenheimer starts RLJ Lodging Trust at Outperform with $20 price target
04/21/22 Oppenheimer
RLJ Lodging Trust initiated with an Outperform at Oppenheimer
01/14/22 Baird
RLJ Lodging Trust upgraded to Outperform from Neutral at Baird
RLJ RLJ Lodging Trust
$10.86 /

-0.26 (-2.34%)

Recommendations
Pebblebrook Hotel price target lowered to $22 from $26 at Barclays » 06:12
07/07/22
07/07
06:12
07/07/22
06:12
PEB

Pebblebrook Hotel

$16.67 /

-0.315 (-1.86%)

Barclays analyst Anthony…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PEB Pebblebrook Hotel
$16.67 /

-0.315 (-1.86%)

PEB Pebblebrook Hotel
$16.67 /

-0.315 (-1.86%)

06/24/22 Stifel
Pebblebrook Hotel price target lowered to $23.25 from $26.25 at Stifel
03/23/22 SMBC Nikko
Pebblebrook Hotel initiated with an Outperform at SMBC Nikko
01/10/22 BofA
Pebblebrook Hotel downgraded to Neutral as BofA restacks Lodging ratings
01/10/22 Raymond James
Pebblebrook Hotel upgraded to Outperform from Market Perform at Raymond James
PEB Pebblebrook Hotel
$16.67 /

-0.315 (-1.86%)

Recommendations
Park Hotels & Resorts price target lowered to $18 from $22 at Barclays » 06:12
07/07/22
07/07
06:12
07/07/22
06:12
PK

Park Hotels & Resorts

$13.09 /

-0.53 (-3.89%)

Barclays analyst Anthony…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PK Park Hotels & Resorts
$13.09 /

-0.53 (-3.89%)

PK Park Hotels & Resorts
$13.09 /

-0.53 (-3.89%)

06/01/22 Truist
Park Hotels & Resorts upgraded to Buy from Hold at Truist
05/03/22 Deutsche Bank
Park Hotels & Resorts price target raised to $28 from $26 at Deutsche Bank
03/30/22 Jefferies
Jefferies downgrades Park Hotels & Resorts, prefers Host Hotels
03/30/22 Jefferies
Host Hotels upgraded to Buy at Jefferies on recovery prospects
PK Park Hotels & Resorts
$13.09 /

-0.53 (-3.89%)

PK Park Hotels & Resorts
$13.09 /

-0.53 (-3.89%)

Recommendations
Host Hotels price target lowered to $22 from $23 at Barclays » 06:12
07/07/22
07/07
06:12
07/07/22
06:12
HST

Host Hotels

$15.47 /

-0.35 (-2.21%)

Barclays analyst Anthony…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
HST Host Hotels
$15.47 /

-0.35 (-2.21%)

HST Host Hotels
$15.47 /

-0.35 (-2.21%)

06/01/22 Truist
Host Hotels price target raised to $21 from $19 at Truist
05/06/22 Deutsche Bank
Host Hotels price target raised to $26 from $23 at Deutsche Bank
03/30/22 Jefferies
Jefferies downgrades Park Hotels & Resorts, prefers Host Hotels
03/30/22 Jefferies
Host Hotels upgraded to Buy at Jefferies on recovery prospects
HST Host Hotels
$15.47 /

-0.35 (-2.21%)

HST Host Hotels
$15.47 /

-0.35 (-2.21%)

HST Host Hotels
$15.47 /

-0.35 (-2.21%)

Downgrade
Rockwool downgraded to Underperform from Neutral at BofA » 06:12
07/07/22
07/07
06:12
07/07/22
06:12
RKWBF

Rockwool

/

+

BofA analyst Arnaud…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
RKWBF Rockwool
/

+

07/06/22 Barclays
Rockwool price target lowered to DKK 1,750 from DKK 2,000 at Barclays
06/10/22 Berenberg
Rockwool price target lowered to DKK 2,100 from DKK 2,700 at Berenberg
05/20/22 Societe Generale
Rockwool upgraded to Hold from Sell at Societe Generale
03/17/22 JPMorgan
Rockwool initiated with an Underweight at JPMorgan
RKWBF Rockwool
/

+

Recommendations
DiamondRock price target lowered to $10 from $11 at Barclays » 06:12
07/07/22
07/07
06:12
07/07/22
06:12
DRH

DiamondRock

/

+

Barclays analyst Anthony…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
DRH DiamondRock
/

+

DRH DiamondRock
/

+

06/01/22 Truist
DiamondRock price target raised to $11 from $9 at Truist
05/18/22 Deutsche Bank
DiamondRock price target raised to $12 from $11 at Deutsche Bank
01/10/22 Raymond James
DiamondRock downgraded to Market Perform from Outperform at Raymond James
01/10/22 Raymond James
DiamondRock downgraded to Market Perform from Outperform at Raymond James
DRH DiamondRock
/

+

Upgrade
Adverum Biotechnologies upgraded to Buy from Hold at Truist » 06:12
07/07/22
07/07
06:12
07/07/22
06:12
ADVM

Adverum Biotechnologies

$1.23 /

+0.045 (+3.81%)

Truist analyst Joon Lee…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ADVM Adverum Biotechnologies
$1.23 /

+0.045 (+3.81%)

ADVM Adverum Biotechnologies
$1.23 /

+0.045 (+3.81%)

03/29/22 Chardan
Adverum Biotechnologies transferred with Neutral at Chardan
07/23/21
Fly Intel: Top five analyst downgrades
07/23/21 Goldman Sachs
Adverum Biotechnologies downgraded to Neutral from Buy at Goldman Sachs
07/23/21 SVB Leerink
Adverum Biotechnologies price target lowered to $2 from $5
ADVM Adverum Biotechnologies
$1.23 /

+0.045 (+3.81%)

Recommendations
Chatham Lodging price target lowered to $15 from $16 at Barclays » 06:11
07/07/22
07/07
06:11
07/07/22
06:11
CLDT

Chatham Lodging

$10.31 /

-0.165 (-1.58%)

Barclays analyst Anthony…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CLDT Chatham Lodging
$10.31 /

-0.165 (-1.58%)

CLDT Chatham Lodging
$10.31 /

-0.165 (-1.58%)

04/21/22 Oppenheimer
Oppenheimer starts 'extended stay king' Chatham Lodging at Outperform
04/21/22 Oppenheimer
Chatham Lodging initiated with an Outperform at Oppenheimer
11/09/21 B. Riley
Chatham Lodging price target raised to $16.50 from $15 at B. Riley
09/01/21
Fly Intel: Top five analyst upgrades
CLDT Chatham Lodging
$10.31 /

-0.165 (-1.58%)

Recommendations
Apple Hospitality REIT price target lowered to $19 from $21 at Barclays » 06:11
07/07/22
07/07
06:11
07/07/22
06:11
APLE

Apple Hospitality REIT

/

+

Barclays analyst Anthony…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
APLE Apple Hospitality REIT
/

+

07/01/22 Baird
Apple Hospitality REIT elevated to bullish Fresh Pick at Baird
06/16/22 B. Riley
Apple Hospitality upgraded to Buy on portfolio 'resiliency' at B. Riley
06/16/22 B. Riley
Apple Hospitality REIT upgraded to Buy from Neutral at B. Riley
04/21/22 Oppenheimer
Apple Hospitality REIT initiated with an Outperform at Oppenheimer
APLE Apple Hospitality REIT
/

+

Upgrade
EPR Properties upgraded to Buy from Neutral at Janney Montgomery Scott » 06:11
07/07/22
07/07
06:11
07/07/22
06:11
EPR

EPR Properties

$47.12 /

-0.08 (-0.17%)

Janney Montgomery Scott…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
EPR EPR Properties
$47.12 /

-0.08 (-0.17%)

EPR EPR Properties
$47.12 /

-0.08 (-0.17%)

06/21/22 Truist
EPR Properties price target lowered to $50 from $51 at Truist
08/20/21 RBC Capital
EPR Properties price target raised to $52 from $49 at RBC Capital
07/13/21 Stifel
EPR Properties price target raised to $55 from $49 at Stifel
EPR EPR Properties
$47.12 /

-0.08 (-0.17%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.